Conducting clinical trials during the COVID-19 pandemic—a collaborative trial network response

Robison, Laura; Cho, Yeoungjee; Viecelli, Andrea K.; Johnson, David W.; Hawley, Carmel M.; Valks, Andrea; Paul-Brent, Peta-Anne; Stastny, Ruth; Varghese, Julie; Kiriwandeniya, Charani; Pascoe, Elaine M.; Vergara, Liza A.; Fahim, Magid A.; Boudville, Neil; Krishnasamy, Rathika; Reidlinger, Donna

The unprecedented demand placed on healthcare systems from the COVID-19 pandemic has forced a reassessment of clinical trial conduct and feasibility. Consequently, the Australasian Kidney Trials Network (AKTN), an established collaborative research group known for conducting investigator-initiated global clinical trials, had to efficiently respond and adapt to the changing landscape during COVID-19. Key priorities included ensuring patient and staff safety, trial integrity and network sustainability for the kidney care community. New resources have been developed to enable a structured review and contingency plan of trial activities during the pandemic and beyond.